Nicholas Laccona - FINANCIAL OFFICER, (PFO & PAO) at Bellerophon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Financial Officer, (Pfo & Pao)
Issuer Symbol
BLPH
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nicholas Laccona since 31 Dec 2024

Holdings reported by Nicholas Laccona for Bellerophon Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (right to buy) 50,000 $76,000 $1.52 10 Feb 2023 Direct Common Stock
Common Stock 12,470 $1,294 $0.1038 09 Dec 2022 Direct
Restricted Stock Units 18,000 09 Dec 2022 Direct Common Stock

Transactions reported by Nicholas Laccona for Bellerophon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.